CCNE1 and BRD4 expression and platinum resistance in high-grade serous ovarian cancers

被引：0
|
作者：
Petersen, S. S. [1 ]
Wilson, A. J. [2 ]
Khabele, D. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[2] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2437
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [41] DRDscore can predict platinum-resistance in advanced high-grade serous ovarian cancer
    Li, Y.
    Zhang, X.
    Gao, Y.
    Han, Q.
    Yu, B.
    Wang, T.
    Huang, C.
    He, X.
    Wu, D.
    Guo, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S633 - S633
  • [42] Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients
    Chiara Mignogna
    Nicoletta Staropoli
    Cirino Botta
    Carmela De Marco
    Antonia Rizzuto
    Michele Morelli
    Annalisa Di Cello
    Renato Franco
    Caterina Camastra
    Ivan Presta
    Natalia Malara
    Angela Salvino
    Pierfrancesco Tassone
    Pierosandro Tagliaferri
    Tullio Barni
    Giuseppe Donato
    Anna Di Vito
    Journal of Ovarian Research, 9
  • [43] Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients
    Mignogna, Chiara
    Staropoli, Nicoletta
    Botta, Cirino
    De Marco, Carmela
    Rizzuto, Antonia
    Morelli, Michele
    Di Cello, Annalisa
    Franco, Renato
    Camastra, Caterina
    Presta, Ivan
    Malara, Natalia
    Salvino, Angela
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Barni, Tullio
    Donato, Giuseppe
    Di Vito, Anna
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [44] CCNE1 amplification defines a good prognostic subgroup among BRCAwt/HRDneg advanced high-grade ovarian cancer (HGOC)
    Blanc-Durand, F.
    Ngoi, N. Y. L.
    Rouleau, E.
    Ang, S. Y. R.
    Pautier, P.
    Michels, J.
    Ouali, K.
    Genestie, C.
    Cotteret, S.
    Lim, Y. W.
    Lim, S. E.
    Lim, D.
    Wijaya, S. T.
    Seong, A. C.
    Leary, A.
    Tan, D. S.
    ANNALS OF ONCOLOGY, 2023, 34 : S524 - S525
  • [45] Mitochondrial transcription and translation are upregulated in high-grade serous ovarian cancers
    Koc, Z.
    Swailes, A.
    Koc, E. C.
    Kesterson, J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 99 - 99
  • [46] Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
    Bischof, Katharina
    Knappskog, Stian
    Hjelle, Sigrun M.
    Stefansson, Ingunn
    Woie, Kathrine
    Salvesen, Helga B.
    Gjertsen, Bjorn T.
    Bjorge, Line
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
    Katharina Bischof
    Stian Knappskog
    Sigrun M. Hjelle
    Ingunn Stefansson
    Kathrine Woie
    Helga B. Salvesen
    Bjorn T. Gjertsen
    Line Bjorge
    Scientific Reports, 9
  • [48] Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
    Tan, Jiahong
    Song, Chunyan
    Wang, Daoqi
    Hu, Yigang
    Liu, Dan
    Ma, Ding
    Gao, Qinglei
    BIOSCIENCE REPORTS, 2021, 41 (05)
  • [49] EZH2 Expression in High-Grade Ovarian Serous Carcinoma and Resistance to Therapy
    Reid, Brett
    Saglam, Ozlen
    Permuth, Jennifer
    Sellers, Thomas
    LABORATORY INVESTIGATION, 2019, 99
  • [50] EZH2 Expression in High-Grade Ovarian Serous Carcinoma and Resistance to Therapy
    Reid, Brett
    Saglam, Ozlen
    Permuth, Jennifer
    Sellers, Thomas
    MODERN PATHOLOGY, 2019, 32
12345